Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Chronic Lymphocytic Leukemia (Disease Or Phenotype)

Omim:MTHU020407

Nci:C3163

Msh:D015451

Mondo:MONDO:4948

Medcin:MEDCIN:31473

Mdr:MDR:10025302

Id:c3f1da47-1858-517c-a56e-05416a41357d

Icpc2icd10eng:MTHU046614

Icd10cm:C91.1

Efo:EFO:95

Doid:DOID:1040

Chv:CHV:7331

Results found

Linked to

	Label	Description
	IBRUTINIB::US9108973, Ref 1::US9181263, 1::US9278100, 1 indication Chronic Lymphocytic Leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Fludarabine phosphate indication Chronic Lymphocytic Leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Mechlorethamine indication Chronic Lymphocytic Leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	US9096627, CY190602 indication Chronic Lymphocytic Leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Duvelisib indication Chronic Lymphocytic Leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	acalabrutinib indication Chronic Lymphocytic Leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	prednisone indication Chronic Lymphocytic Leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	venetoclax indication Chronic Lymphocytic Leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Gibberellin A101 indication Chronic Lymphocytic Leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	fludarabine indication Chronic Lymphocytic Leukemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

IBRUTINIB::US9108973, Ref 1::US9181263, 1::US9278100, 1 indication Chronic Lymphocytic Leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Fludarabine phosphate indication Chronic Lymphocytic Leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Mechlorethamine indication Chronic Lymphocytic Leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

US9096627, CY190602 indication Chronic Lymphocytic Leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Duvelisib indication Chronic Lymphocytic Leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

acalabrutinib indication Chronic Lymphocytic Leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

prednisone indication Chronic Lymphocytic Leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

venetoclax indication Chronic Lymphocytic Leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Gibberellin A101 indication Chronic Lymphocytic Leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

fludarabine indication Chronic Lymphocytic Leukemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.